U.S. Government Will Test Ibogaine As An Addiction Treatment

Non-psychedelic version of ibogaine developed by Delix Therapeutics to be studied by the National Institute on Drug Abuse as a medicine for opioid, methamphetamine, and cocaine substance use disorders.